Ozlem Bilen MD🫀FACC (@ozlembilen2) 's Twitter Profile
Ozlem Bilen MD🫀FACC

@ozlembilen2

Chief of Cardiology @EmoryUniversityHospital Alum@BCM@Hacettepe #cvHCM #cvVHD #echofirst #CardiacImaging Mom of 3💎

ID: 773668890681442304

calendar_today07-09-2016 23:46:52

2,2K Tweet

3,3K Followers

489 Following

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 (@drmarthagulati) 's Twitter Profile Photo

🚨Our paper is live today on JACC Journals Sex Differences in Association of Physical Activity With All-Cause & Cardiovascular Mortality 🫀Women derived greater gains in mortality risk reduction from equivalent doses of physical activity🆚men Smidt Heart Institute at Cedars-Sinai rb.gy/m7l835

🚨Our paper is live today on <a href="/JACCJournals/">JACC Journals</a> 

Sex Differences in Association of Physical Activity With All-Cause &amp; Cardiovascular Mortality
🫀Women derived greater gains in mortality risk reduction from equivalent doses of physical activity🆚men
<a href="/SmidtHeart/">Smidt Heart Institute at Cedars-Sinai</a>
rb.gy/m7l835
Mehmet Asim Bilen,MD (@bilenma) 's Twitter Profile Photo

Ozlem Bilen MD🫀FACC Emory Department of Medicine Thrilled to congratulate my amazing wife on her well-deserved new position! 🎉 Your talent, dedication, and hard work continue to inspire me every day. #ProudHusband

Emory Department of Medicine (@emorydeptofmed) 's Twitter Profile Photo

📣Please join us in congratulating our latest group of faculty members who were promoted during the 2023–2024 cycle, eff. 9/1 (additional promotions are pending)! ➡️View full list of promotions in our March Faculty Development Bulletin Newsletter: bit.ly/43hduww

📣Please join us in congratulating our latest group of faculty members who were promoted during the 2023–2024 cycle, eff. 9/1 (additional promotions are pending)! 

➡️View full list of promotions in our March Faculty Development Bulletin Newsletter: bit.ly/43hduww
JAHA (@jaha_aha) 's Twitter Profile Photo

The longest‐term study of mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) supports continued safety and effectiveness of mavacamten for over 3 years in obstructive HCM. #AHAJournals Ahmad Masri ahajrnls.org/3WnnYcg

The longest‐term study of mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) supports continued safety and effectiveness of mavacamten for over 3 years in obstructive HCM. #AHAJournals <a href="/MasriAhmadMD/">Ahmad Masri</a> ahajrnls.org/3WnnYcg
American Society of Echocardiography (@ase360) 's Twitter Profile Photo

We are pleased to share a new #HCM poster with you all, developed with support from Bristol Myers Squibb! Use this link to download the poster, "A Practical Approach to Echocardiographic Imaging in Patients with Hypertrophic Cardiomyopathy." bit.ly/3lLHKeI

We are pleased to share a new #HCM poster with you all, developed with support from <a href="/bmsnews/">Bristol Myers Squibb</a>!

Use this link to download the poster, "A Practical Approach to Echocardiographic Imaging in Patients with Hypertrophic Cardiomyopathy." bit.ly/3lLHKeI
Emory Department of Medicine (@emorydeptofmed) 's Twitter Profile Photo

“My life has come to a full circle and it’s a magical moment.” Meet Dr. Ozlem Bilen, incoming Section Chief of Cardiology for Emory University Hospital. This appointment marks a historic milestone as she becomes the first woman to hold this position! 🔗bit.ly/3V7Rtg0

“My life has come to a full circle and it’s a magical moment.” Meet Dr. Ozlem Bilen, incoming Section Chief of Cardiology for Emory University Hospital. This appointment marks a historic milestone as she becomes the first woman to hold this position! 🔗bit.ly/3V7Rtg0
American College of Cardiology (@accintouch) 's Twitter Profile Photo

🔑 Tachycardia-induced cardiomyopathy is characterized by a dilated CM w/ moderate to severe biventricular systolic dysfunction and lack of hypertrophy. Mitral insufficiency may be present. Read more key points from a state-of-the-art review on AiCM: bit.ly/4e8Mkgn

🔑 Tachycardia-induced cardiomyopathy is characterized by a dilated CM w/ moderate to severe biventricular systolic dysfunction and lack of hypertrophy. Mitral insufficiency may be present.

Read more key points from a state-of-the-art review on AiCM: bit.ly/4e8Mkgn
Ahmad Masri (@masriahmadmd) 's Twitter Profile Photo

#Aficamten 1/6 presentation. Follow along Here are the results of the #SEQUOIA #HCM #whyCMR substudy (aficamten vs placebo on oHCM) which is also simultaneously published in JACC Journals #CardioTwitter

#Aficamten 1/6 presentation. Follow along 

Here are the results of the #SEQUOIA #HCM #whyCMR substudy (aficamten vs placebo on oHCM) which is also simultaneously published in <a href="/JACCJournals/">JACC Journals</a> 
#CardioTwitter
Kendra J. Grubb M.D. (@kendragrubb) 's Twitter Profile Photo

Starting TODAY - the Emory University Division of Cardiothoracic Surgery will have its first PROFESSOR of Surgery who is a woman! It’s time! #SomeWomanHasToBeFirst

Starting TODAY - the Emory University Division of Cardiothoracic Surgery will have its first PROFESSOR of Surgery who is a woman!

It’s time!

#SomeWomanHasToBeFirst